- The trend backdrop is active with a 1-week active streak.
- Price is above the Trend Line, keeping the weekly tape constructive.
- Price is above Fair Value, showing premium demand versus the model.
- Activity pressure is positive on the latest completed week.
FPH
NZE
Week ended 31 Jul 2026
Weekly Investor Report
Fisher & Paykel Healthcare Corporation Limited · Healthcare · Medical Instruments & Supplies
Latest close
40.69 NZD
3.2%
latest week
Weekly setup
Constructive, but selective
The weekly trend is active. Price is 7.3% above the Trend Line and sits at 87.9% of its 52-week range. The latest completed week returned 3.2%, after a 2.5% four-week move. The latest news-sentiment score is 55/100. Near-term considerations: volume confirmation is below normal.
Setup score
57
out of 100
Latest Close
40.69 NZD
31 Jul 2026
1W Return
3.2%
latest completed week
4W Return
2.5%
short-term follow-through
12W Return
15.6%
quarterly tape
Trend Breadth
65.4%
34 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- Activity pressure is weak, so confirmation is not yet broad enough.
- 13 reversal markers appear in the recent smart-money tape.
- Price is close to its 52-week high; watch for continuation or exhaustion.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
3.2%
Latest completed week; four-week move 2.5%.
Indicator stack
39/72
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Positive 56.34%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
55/100
44 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is active. Price is 7.3% above the Trend Line and sits at 87.9% of its 52-week range. The latest completed week returned 3.2%, after a 2.5% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
6 Feb
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.4412-week average 0.25
12-week confirmation
Trend active1/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure5/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership8/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.44Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers1313 reversal markers
No recent accumulation markers. 13 reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 2.5% over four weeks, 15.6% over 12 weeks, and 13.6% over one year. The current trend has remained active for 1 consecutive weeks.
Performance by holding period
Active trend streak1 weeks
Active weeks in one year34
Trend breadth65.4%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure0.80Latest activity-pressure read.
Pressure change89.9%Four-week change in activity pressure.
Leadership5.31Latest relative-leadership reading.
RS change44.1%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment55/100
Weighted news tone is neutral across 44 relevant articles.
13 positive · 27 neutral · 4 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-2.9%Distance below the 52-week high.
13-week volatility4.1%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
6 Feb
6 Mar
3 Apr
1 May
29 May
26 Jun
31 Jul
Weeks higher13 of 2613 weeks finished lower.
Best week+9.6%Week of 27 Feb.
Worst week-8.2%Week of 13 Feb.
Latest week+3.2%Week of 31 Jul.
Shape of recent returns
Strong gains4
Modest gains9
Flat weeks0
Modest losses9
Sharp losses4
Recent vol4.1%13-week weekly-return volatility.
Base vol3.6%52-week weekly-return volatility.
Up/down split29/23Count of positive and negative weeks in the 52-week window.
Average skew2.8% / -2.8%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorNZ Healthcare
4-week rank8 / 14
Group average7.0%
Trend breadth42.9%
Trend42.9%active weekly trend signals
MD85.7%positive activity pressure
RS57.1%positive relative leadership
Four-week leaders
IndustryNZ Medical Instruments & Supplies
4-week rank1 / 1
Group average2.5%
Trend breadth100.0%
Trend100.0%active weekly trend signals
MD100.0%positive activity pressure
RS100.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape55/100
Trend, activity pressure, participation, and risk combine to a 55/100 tape read.
Indicator analysis32/100Latest 12-week confirmation: trend 1/12, activity pressure 5/12, relative leadership 8/12.
Activity pressure 0.44; 13 reversal markers Next-Week ExpectancyPositive 56.34%Next-week expectancy is positive with a 56.34% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment55/100Weighted news tone is neutral across 44 relevant articles.
GE HealthCare’s (NASDAQ:GEHC) Q2 CY2026: Beats On Revenue, Stock Soars Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 31 Jul 2026 | 40.69 NZD | 3.2% | 37.94 NZD | 32.63 NZD | 0.80 | 5.31 | 1.5M | On |
| 24 Jul 2026 | 39.42 NZD | -1.3% | 37.84 NZD | 32.52 NZD | 0.82 | 1.59 | 2.0M | Off |
| 17 Jul 2026 | 39.93 NZD | -0.8% | 37.79 NZD | 32.42 NZD | 0.76 | 3.52 | 1.5M | Off |
| 10 Jul 2026 | 40.25 NZD | 1.4% | 37.69 NZD | 32.31 NZD | 0.64 | 3.73 | 1.6M | Off |
| 3 Jul 2026 | 39.71 NZD | 3.3% | 37.60 NZD | 32.21 NZD | 0.42 | 3.68 | 2.6M | Off |
| 26 Jun 2026 | 38.45 NZD | 1.1% | 37.54 NZD | 32.10 NZD | -0.10 | 1.35 | 193.6K | Off |
| 19 Jun 2026 | 38.04 NZD | -2.7% | 37.50 NZD | 32.01 NZD | -0.21 | 0.24 | 1.6M | Off |
| 12 Jun 2026 | 39.11 NZD | 6.1% | 37.45 NZD | 31.91 NZD | -0.55 | 3.81 | 535.0K | Off |
| 5 Jun 2026 | 36.86 NZD | -0.3% | 37.40 NZD | 31.81 NZD | -0.90 | -0.41 | 394.2K | Off |
| 29 May 2026 | 36.97 NZD | 9.4% | 37.45 NZD | 31.72 NZD | -1.00 | -0.79 | 4.6M | Off |
| 22 May 2026 | 33.81 NZD | 3.8% | 37.45 NZD | 31.63 NZD | -1.24 | -7.58 | 2.8M | Off |
| 15 May 2026 | 32.57 NZD | -7.5% | 37.51 NZD | 31.56 NZD | -1.28 | -10.93 | 3.3M | Off |
| 8 May 2026 | 35.19 NZD | -1.9% | 37.60 NZD | 31.52 NZD | -1.13 | -5.51 | 2.0M | Off |
| 1 May 2026 | 35.87 NZD | 0.6% | 37.63 NZD | 31.46 NZD | -0.95 | -2.79 | 2.7M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.